HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Author(s) -
Charles D. Wells,
J. Peter Cegielski,
Lisa Nelson,
Kayla F. Laserson,
Timothy H. Holtz,
Alyssa Finlay,
Kenneth G. Castro,
Karin Weyer
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/518665
Subject(s) - tuberculosis , medicine , outbreak , case fatality rate , public health , transmission (telecommunications) , immunology , multiple drug resistance , virology , mycobacterium tuberculosis , rifampicin , intensive care medicine , drug resistance , environmental health , population , biology , microbiology and biotechnology , pathology , electrical engineering , engineering , nursing
Multidrug-resistant (MDR) tuberculosis (TB) has emerged as a global epidemic, with ~425,000 new cases estimated to occur annually. The global human immunodeficiency virus (HIV) infection epidemic has caused explosive increases in TB incidence and may be contributing to increases in MDR-TB prevalence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom